The physician's role in women's decision making about hormone replacement therapy

被引:42
作者
Newton, KM
Lacroix, AZ
Leveille, SG
Rutter, C
Keenan, NL
Anderson, LA
机构
[1] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA
[2] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA
[3] NIA, NIH, Bethesda, MD 20892 USA
[4] Ctr Dis Control & Prevent, Natl Ctr Chron Dis Prevent & Hlth Promot, Atlanta, GA USA
关键词
D O I
10.1016/S0029-7844(98)00272-5
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: To ascertain the sources of information women use when making decisions about hormone replacement therapy (HRT). Methods: A cross-sectional, population-based computer-assisted telephone survey of 1082 randomly selected women aged 50-80 years (80.3% response rate) was conducted at Group Health Cooperative of Puget Sound, a large staff-model health maintenance organization in Washington state. Results: Overall, 460 participants (42.5%) were current HRT users, 226 (20.9%) were past users,nd 396 (36.6%) were never users. Discussions with physicians dominated as the major source of information used in decision making by current (83.4%) and past (65.5%) users, but were less often cited by never users (44.4%); printed material was used by 44.5% of women. Although 72.1% of current users reported that the amount of information received from their physician about the benefits of HRT was about right, only 48.2% of past users and 33.6% of never users shared this view (P < .001 current versus never), and 13.3% of current users, 32.6% of past users and 58% of never users reported receiving no information from their physician about HRT's benefits. Conclusion: Hormone replacement therapy use is strongly related to interactions between women and their physicians. Many women use written materials to make decisions about HRT. A large proportion of women feel inadequately informed about HRT's risks and benefits. Much work remains to be accomplished toward meeting the goal of the US Preventive Services Task Force that all perimenopausal and postmenopausal women be counseled about the potential benefits and risks of HRT. (Obstet Gynecol 1998;92:580-4. (C) 1998 by The American College of Obstetricians and Gynecologists.).
引用
收藏
页码:580 / 584
页数:5
相关论文
共 24 条
[1]  
[Anonymous], 1996, GUID CLIN PREV SERV
[2]   PREVALENCE AND DETERMINANTS OF ESTROGEN REPLACEMENT THERAPY IN ELDERLY WOMEN [J].
CAULEY, JA ;
CUMMINGS, SR ;
BLACK, DM ;
MASCIOLI, SR ;
SEELEY, DG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1990, 163 (05) :1438-1444
[3]   PERIMENOPAUSAL WOMENS VIEWS ON TAKING HORMONE REPLACEMENT THERAPY TO PREVENT OSTEOPOROSIS [J].
DRAPER, J ;
ROLAND, M .
BRITISH MEDICAL JOURNAL, 1990, 300 (6727) :786-788
[4]   ESTROGEN REPLACEMENT THERAPY - A SURVEY OF WOMENS KNOWLEDGE AND ATTITUDES [J].
FERGUSON, KJ ;
HOEGH, C ;
JOHNSON, S .
ARCHIVES OF INTERNAL MEDICINE, 1989, 149 (01) :133-136
[5]  
Gass MLS, 1997, MENOPAUSE, V4, P19
[6]  
GRIFFITHS F, 1995, BRIT J GEN PRACT, V45, P477
[7]  
HANADA VL, 1996, J AM GERIATR SOC, V44, P1
[8]   ARE WOMEN USING POSTMENOPAUSAL ESTROGENS - A COMMUNITY SURVEY [J].
HARRIS, RB ;
LAWS, A ;
REDDY, VM ;
KING, A ;
HASKELL, WL .
AMERICAN JOURNAL OF PUBLIC HEALTH, 1990, 80 (10) :1266-1268
[9]   SELECTION TO POSTMENOPAUSAL THERAPY BY WOMENS CHARACTERISTICS [J].
HEMMINKI, E ;
MALIN, M ;
TOPO, P .
JOURNAL OF CLINICAL EPIDEMIOLOGY, 1993, 46 (03) :211-219
[10]   ATTITUDES TOWARDS AND LEVEL OF INFORMATION ON PERIMENOPAUSAL AND POSTMENOPAUSAL HORMONE REPLACEMENT THERAPY AMONG NORWEGIAN WOMEN [J].
HUNSKAAR, S ;
BACKE, B .
MATURITAS, 1992, 15 (03) :183-194